Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04100148 · ClinicalTrials.gov registry record · NA

SyncAV Post-Market Trial

A NA study of Congestive Heart Failure, sponsored by Abbott Medical Devices.

Active
Registry status
NA
Development phase
1,686
Enrollment target
20
Study locations

NCT04100148 is a NA study of Congestive Heart Failure that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 1,686 participants, above the 297-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (468% higher). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04100148, a NA study of Congestive Heart Failure, is active but no longer recruiting, sponsored by Abbott Medical Devices.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,686 participants
Enrollment target
20
Study locations

Study Summary

The SyncAV Post-Market Trial is a prospective, randomized, multi-center trial performed to determine if cardiac resynchronization therapy (CRT) devices programmed with SyncAV ON improve long-term CRT response compared to devices programmed with conventional CRT through evaluation of changes in left ventricular (LV) reverse remodeling.

Conditions Studied

Congestive Heart Failure

Interventions

  • DEVICE SyncAV programmed ON
  • DEVICE Fixed AV delay

Study Locations (20)

California

  • Comprehensive Cardiovascular - Bakersfield
  • Cardiovascular Consultants Heart Center - Fresno
  • USC University Hospital - Los Angeles

New Jersey

  • Deborah Heart & Lung Center - Browns Mills
  • Cardiovascular Associates of the Delaware Valley - Haddon Heights
  • Lourdes Cardiology Services - Voorhees Township

Arizona

  • Arizona Cardiovascular Research Center - Phoenix
  • HonorHealth - Scottsdale

Florida

  • Shands at the University of Florida - Gainesville
  • Heart Rhythm Solutions - Hollywood

Georgia

  • Piedmont Heart Institute - Atlanta
  • Emory University Hospital - Atlanta

Alabama

  • Heart Center Research, LLC. - Huntsville

Colorado

  • Colorado Heart & Vascular, P.C. - Lakewood

Iowa

  • Iowa Heart Center - West Des Moines

Trial Details

FieldValue
Enrollment Target 1,686 participants
Start Date 2019-10-03
Est. Completion 2026-06-30
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04100148

The ClinicalTrials.gov registry entry for NCT04100148 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,686 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 297-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (468% higher). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which SyncAV programmed ON is the first listed.

NCT04100148 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, New Jersey, Arizona.

Frequently Asked Questions

What is clinical trial NCT04100148 about?

NCT04100148 is a clinical study titled "SyncAV Post-Market Trial". The SyncAV Post-Market Trial is a prospective, randomized, multi-center trial performed to determine if cardiac resynchronization therapy (CRT) devices programmed with SyncAV ON improve long-term CRT response compared to devices programmed with conventional CRT through evaluation of changes in left ...

What is the current status of trial NCT04100148?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,686 participants. The study started on 2019-10-03. Estimated completion is 2026-06-30.

What conditions does trial NCT04100148 study?

This clinical trial studies the following conditions: Congestive Heart Failure.

What interventions are being tested in trial NCT04100148?

The interventions under investigation include: SyncAV programmed ON (DEVICE), Fixed AV delay (DEVICE).

Who is sponsoring clinical trial NCT04100148?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04100148 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Congestive Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Congestive Heart Failure

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.